Side-by-side IPO readiness, funding history, and valuation comparison. Data sourced by TechStackIPO.
Scores, valuations, and signals for OpenAI, Spring Health, and 370+ companies. 5-min read every Tuesday.
OpenAI is valued at $852B — the world's most valuable AI company, backed by $27B in funding. Track IPO readiness score, funding rounds, and timeline.
| Industry | Artificial Intelligence |
| Stage | Pre-IPO |
| IPO Status | Pre-IPO |
| Valuation | $852B |
| Total Funding | $55.4B |
| Headquarters | San Francisco, CA |
Precision mental health benefits platform for employers, using ML to personalize care.
| Industry | Healthcare Technology |
| Stage | Series F |
| IPO Status | Pre-IPO |
| Valuation | $3.3B |
| Total Funding | $370M |
| Headquarters | New York, NY |
OpenAI is valued at $852B. Spring Health is valued at $3.3B. Both valuations are based on the most recent private funding rounds tracked by TechStackIPO.
OpenAI has raised $55.4B. Spring Health has raised $370M.
OpenAI is currently pre-IPO. Spring Health is currently pre-IPO. Track both on TechStackIPO for S-1 filings and IPO announcements.
OpenAI operates in Artificial Intelligence, while Spring Health operates in Healthcare Technology.
OpenAI is a Artificial Intelligence company valued at $852B with $55.4B raised. Spring Health is a Healthcare Technology company valued at $3.3B with $370M raised. See TechStackIPO's full side-by-side comparison for IPO readiness scores, funding timelines, and investor data.
Accredited investors can access pre-IPO shares in OpenAI and Spring Health through secondary market platforms, pre-IPO funds, and broker-dealer platforms that facilitate private company transactions. TechStackIPO's marketplace section tracks available access options for both companies. Pre-IPO investments carry higher risk and limited liquidity.